Skip to main content

Table 6 Distribution of genotypes in patients with AT and in patients without thyroid impairment

From: Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha

SNP Genotypes AT (n=18) No thyroid impairment (n=62)
C1858T CC 12 (66.7%) 49 (79.0%)
  CT 6 (33.3%) 12 (19.4%)
  TT 0 (0.0%) 1 (1.6%)
  p=0.41034
A49G AA 7 (38.9%) 26 (41.9%)
  AG 11 (61.1%) 36 (58.1%)
  GG 0 (0.0%) 0 (0.0%)
  p=0.81720
C(−318)T CC 14 (77.8%) 47 (75.8%)
  CT 4 (22.2%) 13 (21.0%)
  TT 0 (0.0%) 2 (3.2%)
  p=0.74153